Backs FY23 adjusted EBITDA view $1.85B-$2B. The company continues to pursue the sale of its Cosmetic Ingredients business, Lucas Meyer Cosmetics, it said in a regulatory filing. In addition, the company is executing additional divestiture actions within the portfolio to strengthen its capital structure and unlock further value creation for its shareholders.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on IFF:
- Early notable gainers among liquid option names on September 20th
- Nvidia upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls
- IFF downgraded to Equal Weight from Overweight at Morgan Stanley
- IFF price target lowered to $70 from $105 at Mizuho
- IFF price target lowered to $82 from $102 at BofA